Feedback    Advertise    Submit Papers    Reprints    About    Help    Contact   
Upstream Processing Downstream Processing Manufacturing Analytical Facilities
Archive by Issue Archive by Article Type Supplements
CMC Forum Press Releases
Avid Bioservices
Kelly Pisarev Lord
BioProcess International, Vol. 8, No. 7, July–August 2010, p. 30
 



Avid Bioservices offers a fresh approach to the Contract Manufacturing organization (CMO)–client relationship: fully integrated services across the process chain, including cell line and process development, analytical methods development, cGMP manufacturing, fill/finish, regulatory submission, and commercialization of biologic drug product or drug substance. our expertise enables our clients to succeed in their ventures.

As a wholly owned subsidiary of Peregrine Pharmaceuticals, a clinical-stage biotech company with a management team experienced in the commercialization of therapeutic proteins, we know what it takes to navigate our clients’ biologic from concept to commercialization. This allows us to provide our clients with unique insights to manage the challenges of drug development and commercialization while mitigating risk, reducing costs and accelerating time to market.

Capable of Meeting Market DeMand

At Avid, we strive to be the partner of choice by providing a more comprehensive approach to contract services and meeting the market demand. Manufacturing biologics for Peregrine and third party clients enables us to provide our clients with guidance outside of the realm of a typical CMO, in addition to providing flexible solutions.

We pride ourselves on being able to apply our knowledge and experience to benefit our clients and their projects throughout the process. our manufacturing expertise spans from clinical to commercial production, including commercial API production since 2005.

Our facility currently has 2,400 L of total capacity, including 100-L, 300-L, and two 1,000-L bioreactors, with the potential for expansion of an additional 6,000 L, taking advantage of disposable technology. our established partnerships further advance our expertise and scale-up capacity.

Dedication to Superior Quality and Customer Service

Our proven track record of quality and customer service speaks for itself. Since 2002, our successful inspection track record continues to grow, ranging from audits by the U.S. FDA and the State of California, as well as other regulatory agencies and clients. Project management acts on behalf of the client and drives the process internally and externally, from start to finish, ensuring timelines are met and product is delivered on time. our project management team has extensive experience collaborating and partnering with our clients and contributing to their success. This is further backed by the strong foundation of our management team and their commitment to meeting the needs of our clients.

Avid is a full-service contract biotech company specializing in the development and production of monoclonal antibodies, recombinant proteins and enzymes. our fully integrated capabilities include the following:

  • Cell line development

  • Cell banking

  • Mammalian cell culture process development

  • Purification process development

  • Analytical assay development

  • Protein characterization

  • Process optimization, scale-up, and validation

  • cGMP clinical and commercial manufacturing

  • Aseptic and bulk filling

  • Stability testing

  • Quality assurance and quality control testing

  • Regulatory submission

Author Details
Kelly Pisarev Lord is marketing manager for Avid Bioservices, Inc., 14282 Franklin Avenue, Tustin, California, 92780; 1-714-508-6100; businessdevelopment@avidbio.com, www.avidbio.com.

 
| | Share
Biopharmaceutical Production
Facility Design Strategies for Single-Use Technologies

Please join us for a free webinar addressing strategies for facility design in biopharmaceutical manufacturing:

Wednesday, 29 February 2012
8:00 AM and 1:00 PM EST

Presented by:

Ingrid Long, MSc
Research Engineer
GE Healthcare Life Sciences

Register today!

During the webinar, Ms. Long will discuss the impact of different strategies for facility design, with a focus on the following topics:

* Replacement of traditional equipment with the single-use equivalent
* Biopharmaceutical manufacturing in a single room
* Benefits of facility design with respect to cost, risk, and flexibility

Register today!


Nine Conferences — One Location: Hilton Bayfront (San Diego, CA)
Webinars   
Subscribe   
Reprints   
Contact   
About   
Informa plc
©2002 - 2009 BioProcess International
Ph: 508-616-5550